of Lipopolysaccharide in Tumor-Bearing Mice Pretreated with BCG. Tohoku J. exp. Med., 1986, 150 (4), [391][392][393][394][395][396][397][398][399] The antitumor activity of lipopolysaccharide (LPS) was investigated in BCG-treated mice. 03H/He mice and CDF1 mice were injected with BCG and then were inoculated with syngeneic mouse hepatoma MH134 and mastocytoma P815 respectively. Hemorrhagic necrosis and retarded growth of tumor were observed after an intravenous (i.v.) injection of LPS, when tumor cells had been inoculated subcutaneously (s.c.). However an intraperitoneal (i.p.) injection of BCG plus LPS did not increase the mean survival time of mice that had been inoculated with tumor cells i.p. Sera from mice that had been treated with BCG plus LPS i.v. were cytotoxic for cultured tumor cells. These results seemed to indicate that growth-inhibitory effects of LPS on tumors inoculated s.c. were mediated by a humoral factor. LPS ; BCG ; antitumor effect
The antitumor effect of Mycobacterium bovis, strain BCG in experimental neoplasms has been well documented. Also it is accepted that the bacterial lipopolysaccharide (LPS) causes necrosis of tumors in vivo. Recently Carswell et al. (1975) have demonstrated that necrosis of tumors occured by an injection of sera from the animals pretreated with BCG and LPS.
However there have been only a few reports dealing with the antitumor activity of LPS in tumor-bearing animals which had been injected with BCG. No publications are available concerning the effects of LPS in BCG-treated mice which had been inoculated with tumor cells i.p.
In the present study, BCG-treated CDF1 mice and C3H/He mice received s.c. and i.p. inoculations of syngeneic tumor cells and the antitumor effect of LPS was investigated.
MATERIALS AND METHODS
Mice. Male C3H/He mice and hybride CDF1 (BALB/C x DBA/2) mice were purchased from Shizuoka Experimental Animal Farm (Shizuoka). Mice were 6 to 8 weeks old
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at the start of experiments. Tumor cells. Mouse hepatoma MH134, originally induced with carbon tetrachloride in C3H mice and converted into ascites form (Sato et al. 1956 ) has been maintained in C3H/ He mice by i.p. inoculations. P815 (mastocytoma), induced by Dunn and Potter (1957) in DBA/2 mice, has been maintained in ascites by i.p. transplantations in histocompatible CDF1 mice. The tumor cells were harvested from the abdominal cavities and washed with saline immediately before inoculations.
BOG. Lyophilized Mycobacterium bovis, strain BCG (Japanese strain Tokyo No. 172 supplied by the National Institute of Health, Tokyo) were used throughout this series of experiments.
LPS. Lipopolysaccharide (LPS) derived from Escherichia coli was obtained from Difco (Detroit, MI, USA).
Preparation of sera for cytotoxicity test
Mice were injected with 4 mg (2 X 10') viable BCG organisms. After 14 days, 25pg of LPS was injected iv. Blood was taken 2 hr after injection of LPS. The blood from the BOG-treated mice was taken 14 days after injection of BOG and that from LPS-treated mice 2 hr after injection of LPS. Effects of sera on cultured P815 cells P815 cells were cultured in RPMI 1640 medium (Nissui Oo., Tokyo) supplemented with 10% heat-inactivated fetal calf serum. Sera to be tested from ODF1 mice, heated at 56°O 30 min, were added and the cell suspension was incubated in 5% 002 in air at 3T0 for 48 hr.
Viable cells were counted using trypan blue dye exclusion method. Cytotoxicity was expressed by the formula : Cytotoxicity (%) _ (1-a/b) X 100 where "a" is the number of viable cells in culture with test serum and "b" is the number of viable cells in culture without serum.
Values are given in terms of mean +s.D. Student's t-test was used in all statistical evaluations. Any p value less than 0.05 was considered significant.
RESULTS

Effects on tumors
Figs. 1 and 2 before inoculation As shown in Fig, 1 , when P815 cells had been inoculated s.c, in CDF1 mice, an injection of LPS caused hemorrhagic necrosis of tumor and reduction of tumor size (groups 2 and 3). In mice pretreated with BCG plus LPS (group 2) regrowth of tumor was retarded. The mean survival days of the BCG-treated group (group 1, 28.9 ±4.2) and those of the group treated with BCG plus LPS (group 2, 29.9± 5.2) increased significantly as compared with those of the untreated group (group 4, 24.0+ 1.8). However LPS did not prolong the mean survival days significantly ; no statistical difference was observed between groups 1 and 2 and the mean survival days of the LPS-treated group (group 3, 26.2+4.6) were not increased significantly than those of the untreated group. In this experiment all the mice were dead at 41st day after inoculation of tumor cells.
As shown in Fig. 2 , in C3H/He mice which had been inoculated with cells of MH134, an injection of LPS caused necrosis of tumors and reduction of tumor size (groups 2 and 3). However, unlike CDF1 mice, the mean tumor diameter in the group treated with BCG plus LPS (group 2) remained larger than that of LPStreated group (group 3) after the 8 th day following injection of LPS. The prolongation of survival days was statistically significant for the groups treated with BCG (group 1, 30.5+4.2), BCG plus LPS (group 2, 29.3+2.6) or LPS (group 3, 32.4 + 6.3) as compared with those of the untreated group (group 4, 20.9± 2.0). However there was no significant difference in survival time among the three experimental groups. There was no survivor in experimental groups at 52 nd day after inoculation of tumor cells. Effects on tumors inoculated i . p .
As indicated in Table 1 , when 2 X 104 P815 cells were inoculated i.p, the mean survival time of the control group was 14.0+ 1.0 days. Treatment with BCG, LPS or BCG plus LPS was ineffective. No prolongation of survival days was observed. Table 2 summarizes the results of an experiment in which 1 x 105 cells of MH134 were inoculated into C3H/He mice i.p. The mean survival time of the control group was 30.1+6.5 days. The survival time in the BCG-treated group, or LPS-treated group was shortened rather than prolonged as compared with that of the control group. In this case also, treatment with BCG plus LPS did not prolong survival days. However no significant difference in mean survival time was found among the three experimental groups and the control group. As shown in Table 3 , when CDF1 mice received an i.p. inocu][ation of as few as 3 X 103 cells of P815, the mean survival time of the control group was 15.6±0.9 days. Prolongation of the survival time in BCG-injected groups (groups 1 and 2) was statistically significant as compared with that of the control group. However no significant difference in survival days was observed between the BCG-treated group (group 1) and the group treated with BCG plus LPS (group 2). The mean survival time in LPS-treated group (group 3) was not different from that of the control group statistically.
Effects of sera on cultured tumor cells
Neither the serum from LPS-treated mice, nor that from BCG-treated mice was cytotoxic for cultured P815 cells. However the serum from mice treated with BCG plus LPS was highly cytotoxic, suggesting the presence of a cytotoxic factor 
DISCUSSION
Hemorrhagic necrosis of tumors by an injection of bacterial lipopolysaccharide (LPS) has been reported by Shear (1944) . Such necrosis has been observed not only by injection of LPS but also by that of the serum from LPS-treated mice (O'Malley et al. 1962) . Since the publication of reports of Halpern et al. (1958) and Suter et al. (1958) it has widely been known that mice inoculated with BCG become hyperreactive to LPS. Carswell et al. (1975) reported that an injection of the serum from animals treated with BCG plus LPS i.v. Caused hemorrhagic necrosis of transplanted tumors. A factor responsible for the antitumor activity of the serum has been designated tumor necrosis factor (TNF ), which is believed to be a lysosomal enzyme released from activated macrophages (Green et al. 1976 ; Matthews and Watkins 1978) .
So far only a few publications are available concerning the in vivo treatment with BCG and substances of bacterial origin in tumor-bearing animals. Kiger et al. (1980) observed the antitumor effect of Pseudomonas in stead of LPS in the assay using tumor-bearing mice pretreated with BCG. Tamura and Ishida (1984) observed complete regression of tumor in BALB/C mice by treatment with BCG plus LPS. In the present investigation regression of tumor was incomplete and all mice succumed to tumors.
An injection of LPS (15 p g i.v. or 20 p g i.p.) was well tolerated even by BCG-treated mice. Apart from a transient loss of body weight, the mice showed no sign of toxicity.
The antitumor activity of BCG has already been confirmed in experimental animal models. On the other hand, the timing of BCG injection relative to the inoculation of tumor cells has been shown to be very important (Amiel and Berardet 1972; Lavrin et al. 1973; Tokunaga et al. 1974; Proctor et al. 1976; Nedvedova et al. 1978) . It has also been demonstrated that BCG enhances tumor growth in certain situations (Piessens et al. 1970; Baldwin and Pimm 1973; Sparks and Breeding 1974; Ishibashi et al. 1978) . In this study, when BCG was injected after inoculation of tumor cells the mean tumor size was increased in the BCG-treated mice and inhibition by injection of LPS of tumor growth was not observed.
In the treatment with BCG of experimental neoplasms, activated macrophages have been found to play an important role. It is well known also that LPS stimulates macrophages to the release of interferon. However LPS-induced interferon has been shown to be inactivated by heating at 56°C 30 min. Since the serum from the mice treated with BCG and LPS has remained cytotoxic even after heating in the present experiments, it is unlikely that the cytotoxicity is due to the presence of interferon. Therefore the results of cytotoxicity test in vitro seem to indicate the presence of an other-than-interferon serum factor which mediates antitumor activity in vivo. However further investigations are required to find out whether this factor is identical with TNF. Furthermore in the treatment of neoplasms using LPS, the possibility that interleukin 1 mediates antitumor activity should be taken into account (Lovett et al. 1986 ). In the present study, an injection of LPS caused hemorrhagic necrosis and retardation of tumor growth in the BCG-treated mice when tumor cells had been inoculated s.c. The reason remains as yet obscure, however, why an injection of BCG and LPS caused no inhibitory effects on tumor cells inoculated i.p. It would be of importance to investigate more closely effects of LPS on peritoneal macrophages. Experiments are now being carried out along this line.
